These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19378122)

  • 1. Poxvirus tropism for primary human leukocytes and hematopoietic cells.
    Yu Q; Hu N; Ostrowski M
    Methods Mol Biol; 2009; 515():309-28. PubMed ID: 19378122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage.
    Yu Q; Jones B; Hu N; Chang H; Ahmad S; Liu J; Parrington M; Ostrowski M
    Vaccine; 2006 Sep; 24(40-41):6376-91. PubMed ID: 16859816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of different leukocyte cell types to Vaccinia virus infection.
    Sánchez-Puig JM; Sánchez L; Roy G; Blasco R
    Virol J; 2004 Nov; 1():10. PubMed ID: 15555076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropism of Tanapox virus infection in primary human cells.
    Nazarian SH; Barrett JW; Stanford MM; Johnston JB; Essani K; McFadden G
    Virology; 2007 Nov; 368(1):32-40. PubMed ID: 17632198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells.
    Hu N; Yu R; Shikuma C; Shiramizu B; Ostrwoski MA; Yu Q
    Vaccine; 2009 May; 27(22):2994-3006. PubMed ID: 19428911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of antibodies against vaccinia virus DNA polymerase.
    Magee WC; Shahhosseini S; Lin YC; Suresh MR; Evans DH
    J Virol Methods; 2009 Oct; 161(1):44-51. PubMed ID: 19477201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
    Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
    Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.
    Chahroudi A; Chavan R; Kozyr N; Waller EK; Silvestri G; Feinberg MB
    J Virol; 2005 Aug; 79(16):10397-407. PubMed ID: 16051832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia, and Raccoonpox Viruses.
    Roper RL
    Methods Mol Biol; 2017; 1581():121-129. PubMed ID: 28374246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells.
    Harenberg A; Guillaume F; Ryan EJ; Burdin N; Spada F
    Vaccine; 2008 Sep; 26(39):5004-13. PubMed ID: 18691624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts.
    Byrd D; Amet T; Hu N; Lan J; Hu S; Yu Q
    J Virol; 2013 Aug; 87(16):9301-12. PubMed ID: 23785200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2).
    Jourdier TM; Moste C; Bonnet MC; Delisle F; Tafani JP; Devauchelle P; Tartaglia J; Moingeon P
    Gene Ther; 2003 Dec; 10(26):2126-32. PubMed ID: 14625567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A poxvirus of primates. II. Immunology.
    Nicholas AH
    J Natl Cancer Inst; 1970 Nov; 45(5):907-14. PubMed ID: 18605416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a macrophage-tropic GFP-tagged human immunodeficiency virus type 1 (HIV-1) to study viral reservoirs.
    Brown AM
    Methods Mol Biol; 2009; 515():165-75. PubMed ID: 19378134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell tropism of simian T-cell leukaemia virus type 1 and cytokine profiles in relation to proviral load and immunological changes during chronic infection of naturally infected mandrills (Mandrillus sphinx).
    Souquière S; Mouinga-Ondeme A; Makuwa M; Beggio P; Radaelli A; De Giuli Morghen C; Mortreux F; Kazanji M
    J Med Primatol; 2009 Aug; 38(4):279-89. PubMed ID: 19457158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A poxvirus of primates. I. Growth of the virus in vitro and comparison with other poxviruses.
    Nicholas AH
    J Natl Cancer Inst; 1970 Nov; 45(5):897-905. PubMed ID: 18605415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.